NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES

The invention provides a vaccine composition comprising an antigen component and an adjuvant component, wherein the adjuvant component comprises a P-class immunostimulatory oligonucleotide and either a combination of a saponin and a sterol; or an oily phase comprising an oil and, optionally, one or...

Full description

Saved in:
Bibliographic Details
Main Authors Krebs, Richard Lee, Foss, Dennis L, Mwangi, Duncan, Sly, Laurel Mary, Dominowski, Paul Joseph, Cook, Corey Patrick, Rai, Sharath K
Format Patent
LanguageEnglish
French
German
Published 25.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides a vaccine composition comprising an antigen component and an adjuvant component, wherein the adjuvant component comprises a P-class immunostimulatory oligonucleotide and either a combination of a saponin and a sterol; or an oily phase comprising an oil and, optionally, one or more emulsifiers, said oily phase comprising 2-20% v/v of the vaccine composition, wherein said antigen component is an EHV antigen or a Leishmania antigen.
AbstractList The invention provides a vaccine composition comprising an antigen component and an adjuvant component, wherein the adjuvant component comprises a P-class immunostimulatory oligonucleotide and either a combination of a saponin and a sterol; or an oily phase comprising an oil and, optionally, one or more emulsifiers, said oily phase comprising 2-20% v/v of the vaccine composition, wherein said antigen component is an EHV antigen or a Leishmania antigen.
Author Krebs, Richard Lee
Foss, Dennis L
Dominowski, Paul Joseph
Cook, Corey Patrick
Sly, Laurel Mary
Mwangi, Duncan
Rai, Sharath K
Author_xml – fullname: Krebs, Richard Lee
– fullname: Foss, Dennis L
– fullname: Mwangi, Duncan
– fullname: Sly, Laurel Mary
– fullname: Dominowski, Paul Joseph
– fullname: Cook, Corey Patrick
– fullname: Rai, Sharath K
BookMark eNrjYmDJy89L5WTw8PMPc_VRCHN0dvb0c1Vw9vcN8A_2DPH09wsGc4I8gz393BU8fX1D_fyDQzx9Q30cQ_yDIhX8fTzd_f1CnX1c_UM8XVyDeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsamJkYWhpaOhMRFKAEjPL08
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NOUVELLES COMPOSITIONS DE VACCIN COMPRENANT DES OLIGONUCLÉOTIDES IMMUNOSTIMULATEURS
NEUARTIGE NEUARTIGE IMPFSTOFFZUSAMMENSETZUNGEN MIT IMMUNSTIMULIERENDEN OLIGONUKLEOTIDEN
ExternalDocumentID EP3542819A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3542819A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3542819A13
Notes Application Number: EP20190173426
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190925&DB=EPODOC&CC=EP&NR=3542819A1
ParticipantIDs epo_espacenet_EP3542819A1
PublicationCentury 2000
PublicationDate 20190925
PublicationDateYYYYMMDD 2019-09-25
PublicationDate_xml – month: 09
  year: 2019
  text: 20190925
  day: 25
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Zoetis Services LLC
RelatedCompanies_xml – name: Zoetis Services LLC
Score 3.2250547
Snippet The invention provides a vaccine composition comprising an antigen component and an adjuvant component, wherein the adjuvant component comprises a P-class...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190925&DB=EPODOC&locale=&CC=EP&NR=3542819A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOqbokbwI3swe1sEtpXtgRjoCtRs7cI2gk9knwkvg8iM_75dA-iLvl3b5HK95Hq_a--uAM-GmdtGbHS1RIBlTeD_QrPsuKcVdpx19b5pZbJCzmNoFhlvS3PZgPWhFkb2Cf2SzRGFRaXC3it5Xm9_LrEcmVu5e0nWYmrzOgmHjrqPjoV3s_um6oyHxOcOxyrGglLZfKibRv1kNBKB0kmNous2-2QxrotStr89yuQSTn3BrKyuoJGXLTjHh4_XWnDm7d-7Bbk3vd01zBhfEFdZjDCmjCiYez4PqCwCloM5DSibKtTzIsaDkHqROwr5_F3hLp1yFmGX8JA6JLgBZUJCPNOESKvj9lfEPwqv30Kz3JT5HSgoRZaO4m7WSwoDocRCSW-QDvJYQBiUWkUb2n-y6fyzdg8XtR7rlIi--QDN6uMzfxR-t0qepMa-AcRogZA
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokb83IPZ2yKwrWwPxEA3WHVrF7YRfCL7THgZRGb89-0aQF_07doml-sl1_tde3cFeNL03NRiraskHCwrHP8XimHGPaUw46yr9nUjExVyHkVOpL0u9EUDVvtaGNEn9Es0R-QWlXJ7r8R5vfm5xLJEbuX2OVnxqfXLJBxa8i465t7N7OuyNR7aPrMYljHmlExnQ1XX6iejEQ-UjgZ1c94aOc3HdVHK5rdHmZzBsc-ZldU5NPKyDS28_3itDSfe7r2bkzvT216AQ9ncdqX5CGNCbQkzz2cBEUXAYjAjAaFTiXheRFkQEi9yRyGbvUvMJVNGI-zaLCSWHVyCNLFD7ChcpOVh-0vbPwivXkGzXJf5NUgoRYaK4m7WSwoNocRASW-QDvKYQxiUGkUHOn-yufln7RFaTui5S5fQt1s4rXVap0f09TtoVh-f-T33wVXyILT3DfudhH0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+VACCINE+COMPOSITIONS+COMPRISING+IMMUNOSTIMULATORY+OLIGONUCLEOTIDES&rft.inventor=Krebs%2C+Richard+Lee&rft.inventor=Foss%2C+Dennis+L&rft.inventor=Mwangi%2C+Duncan&rft.inventor=Sly%2C+Laurel+Mary&rft.inventor=Dominowski%2C+Paul+Joseph&rft.inventor=Cook%2C+Corey+Patrick&rft.inventor=Rai%2C+Sharath+K&rft.date=2019-09-25&rft.externalDBID=A1&rft.externalDocID=EP3542819A1